国产手术机器人行业正处于从“概念验证”迈向“规模化盈利”的关键转折点。 1月21日,浙商证券在最新研报中称,随着医保局收费目录政策落地和海外市场加速拓展,行业有望从早期发展期步入快速增长期。如果说过去五年是技术追赶期,那么未来五年将是商业化兑现期。 浙商证券称,2024年中国手术机器人市场规模约为72亿元人民币。根据预测,到2032年,这一数字将暴涨至767亿元。这意味着在未来8年间,年复合增长率...
Source Link国产手术机器人行业正处于从“概念验证”迈向“规模化盈利”的关键转折点。 1月21日,浙商证券在最新研报中称,随着医保局收费目录政策落地和海外市场加速拓展,行业有望从早期发展期步入快速增长期。如果说过去五年是技术追赶期,那么未来五年将是商业化兑现期。 浙商证券称,2024年中国手术机器人市场规模约为72亿元人民币。根据预测,到2032年,这一数字将暴涨至767亿元。这意味着在未来8年间,年复合增长率...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.